In any case, future studies should aim to elucidate the molecular pathways involved, particularly those related to insulin signaling, inflammation, and mitochondrial function, to better understand the therapeutic potential of C-LMW in metabolic diseases. The gene discussed is INS; the disease is Other metabolic disease.